mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.01 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |